Breaking News Headlines Today | Ground News

See every side of every news story

pharmatimes.com image

News from pharmatimes.com

pharmatimes.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is pharmatimes.com credible or reliable? Our Factuality score answers both of those questions. When it comes to pharmatimes.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about pharmatimes.com

Where is pharmatimes.com located?pharmatimes.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmatimes.com News

ESMO 2025: J&J Eyes Rybrevant Indication Expansion to HNSCC on Phase II Victory - Pharmaceutical Technology

ESMO 2025: J&J Eyes Rybrevant Indication Expansion to HNSCC on Phase II Victory - Pharmaceutical Technology

57% Center coverage: 14 sources

J&J will now explore Rybrevant's efficacy and safety in a Phase III trial in first-line, EGFR-driven HNSCC and colorectal cancer.See the Story

Tiger, Leopard and Cheetah Undergoing Medical Scans

Cats · El Paso

Tiger, Leopard and Cheetah Undergoing Medical Scans

40% Right coverage: 10 sources

The cats involved were Luca, a four-year-old Amur Tiger; Django, a ten-year-old Mainland Clouded Leopard; and Mo, a four-year-old Southern African Cheetah.See the Story

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

United States · United States

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

Coverage: 2 sources

Advances made in preclinical pipeline addressing neurodegenerative diseasesEvotec receives US$ 25 m payment to support continued progression of joint programs See the Story

Breaking News Topics Related to pharmatimes.com